Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/2565
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel, Mayur M.-
dc.contributor.authorPatel, Santnu L.-
dc.contributor.authorBhadani, Manish N.-
dc.contributor.authorShah, Tejal J.-
dc.contributor.authorAmin, Avani F.-
dc.date.accessioned2011-07-26T06:47:15Z-
dc.date.available2011-07-26T06:47:15Z-
dc.date.issued2009-
dc.identifier.urihttp://hdl.handle.net/123456789/2565-
dc.descriptionActa Pharmaceutica Sciencia,51: 251- 260 (2009)en_US
dc.description.abstractThe aim of the present investigation is to develop a time and pH-dependent system for colon specific drug delivery of mesalamine. The colon specific drug delivery system (CDDS) is designed such that the innermost part consists of a core tablet of mesalamine which is then compression coated with a pH-independent hydrophilic polymer (Hydropropylmethyl cellulose). This is then coated with a pH-dependent methacrylic acid copolymer (Eudragit® S100). The concentration (coating level) of Eudragit® S100 was optimized to provide an enteric coat that allows the tablet to pass intact through the stomach and is targeted to the colon. The coating thickness and grades of HPMC were optimized to set a desired lag time in the intestine. From the in vitro evaluation it can revealed that the developed CDDS can exhibit site-specific drug targeting to the colon.en_US
dc.publisherActa Pharmaceutica Scienciaen_US
dc.relation.ispartofseriesIPFP0027en_US
dc.subjectColonic specific drug deliveryen_US
dc.subjectcompression coatingen_US
dc.subjectenteric coatingen_US
dc.subjectmesalamineen_US
dc.subjectFacuty Paperen_US
dc.subjectPharmacy Faculty Paperen_US
dc.subjectIPFP0027en_US
dc.titleA synchronous colon-specific drug delivery system for orally administered mesalamineen_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0027.pdfIPFP0027139.79 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.